--- title: "Darden Restaurants To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday" type: "News" locale: "en" url: "https://longbridge.com/en/news/291292081.md" description: "Wall Street analysts updated outlooks on several stocks. Key changes include Wedbush raising Replimune's target to $9, Canaccord cutting Strategy's to $130, Barclays upgrading Watts Water and raising its target to $414, Rosenblatt upgrading Comcast to Buy with a $31 target, Goldman increasing State Street's target to $194, Evercore upgrading Owens Corning to Outperform with an $188 target, Cantor Fitzgerald boosting BioCryst Pharma's target to $29, BTIG raising Edwards Lifesciences' target to $110, Baird increasing Taysha Gene Therapies' target to $15, and Argus raising Darden Restaurants' target to $245." datetime: "2026-06-30T13:04:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291292081.md) - [en](https://longbridge.com/en/news/291292081.md) - [zh-HK](https://longbridge.com/zh-HK/news/291292081.md) --- # Darden Restaurants To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. - Wedbush raised the price target for **Replimune Group Inc** (NASDAQ:REPL) from $6 to $9. Wedbush analyst Robert Driscoll maintained a Neutral rating. Replimune shares closed at $11.20 on Monday. See how other analysts view this stock. - Canaccord Genuity cut **Strategy Inc** (NASDAQ:MSTR) price target from $163 to $130. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. Strategy shares closed at $92.68 on Monday. See how other analysts view this stock. - Barclays raised price target for **Watts Water Technologies Inc** (NYSE:WTS) from $317 to $414. Barclays analyst William Grippin upgraded the stock from Equal-Weight to Overweight. Watts Water Technologies shares closed at $358.93 on Monday. See how other analysts view this stock. - Rosenblatt boosted the price target for **Comcast Corp** (NASDAQ:CMCSA) from $24 to $31. Rosenblatt analyst Barton Crockett upgraded the stock from Neutral to Buy. Comcast shares closed at $24.22 on Monday. See how other analysts view this stock. - Goldman Sachs increased **State Street Corp** (NYSE:STT) price target from $168 to $194. Goldman Sachs analyst Alexander Blostein maintained a Buy rating. State Street shares closed at $170.18 on Monday. See how other analysts view this stock. - Evercore ISI Group raised **Owens Corning** (NYSE:OC) price target from $139 to $188. Evercore ISI Group analyst Stephen Kim upgraded the stock from In-Line to Outperform. Owens Corning shares closed at $156.05 on Monday. See how other analysts view this stock. - Cantor Fitzgerald boosted **BioCryst Pharmaceuticals Inc** (NASDAQ:BCRX) price target from $27 to $29. Cantor Fitzgerald analyst Steven Seedhouse maintained an Overweight rating. BioCryst Pharmaceuticals shares closed at $9.55 on Monday. See how other analysts view this stock. - BTIG boosted the price target for **Edwards Lifesciences Corp** (NYSE:EW) from $100 to $110. BTIG analyst Marie Thibault maintained a Buy rating. Edwards Lifesciences shares closed at $91.18 on Monday. See how other analysts view this stock. - Baird increased **Taysha Gene Therapies Inc** (NASDAQ:TSHA) price target from $12 to $15. Baird analyst Jack Allen maintained an Outperform rating. Taysha Gene Therapies shares closed at $6.73 on Monday. See how other analysts view this stock. - Argus Research raised **Darden Restaurants Inc** (NYSE:DRI) price target from $240 to $245. Argus Research analyst John Staszak maintained a Buy rating. Darden shares closed at $205.70 on Monday. See how other analysts view this stock. Considering buying DRI stock? Here’s what analysts think: _Photo via Shutterstock_ ### Related Stocks - [BCRX.US](https://longbridge.com/en/quote/BCRX.US.md) - [EW.US](https://longbridge.com/en/quote/EW.US.md) - [CCZ.US](https://longbridge.com/en/quote/CCZ.US.md) - [DRI.US](https://longbridge.com/en/quote/DRI.US.md) - [MSTR.US](https://longbridge.com/en/quote/MSTR.US.md) - [WTS.US](https://longbridge.com/en/quote/WTS.US.md) - [OC.US](https://longbridge.com/en/quote/OC.US.md) - [STRD.US](https://longbridge.com/en/quote/STRD.US.md) - [REPL.US](https://longbridge.com/en/quote/REPL.US.md) - [TSHA.US](https://longbridge.com/en/quote/TSHA.US.md) - [STRF.US](https://longbridge.com/en/quote/STRF.US.md) - [STRC.US](https://longbridge.com/en/quote/STRC.US.md) - [CMCSA.US](https://longbridge.com/en/quote/CMCSA.US.md) - [STT.US](https://longbridge.com/en/quote/STT.US.md) - [STRK.US](https://longbridge.com/en/quote/STRK.US.md) - [MSTW.US](https://longbridge.com/en/quote/MSTW.US.md) - [IMST.US](https://longbridge.com/en/quote/IMST.US.md) - [MSDD.US](https://longbridge.com/en/quote/MSDD.US.md) - [MSOO.US](https://longbridge.com/en/quote/MSOO.US.md) - [MSST.US](https://longbridge.com/en/quote/MSST.US.md) - [MST.US](https://longbridge.com/en/quote/MST.US.md) - [MSTP.US](https://longbridge.com/en/quote/MSTP.US.md) - [MSTU.US](https://longbridge.com/en/quote/MSTU.US.md) - [MSTX.US](https://longbridge.com/en/quote/MSTX.US.md) - [MSTY.US](https://longbridge.com/en/quote/MSTY.US.md) - [MSTZ.US](https://longbridge.com/en/quote/MSTZ.US.md) - [MTYY.US](https://longbridge.com/en/quote/MTYY.US.md) - [SMST.US](https://longbridge.com/en/quote/SMST.US.md) - [WNTR.US](https://longbridge.com/en/quote/WNTR.US.md) - [07799.HK](https://longbridge.com/en/quote/07799.HK.md) - [09399.HK](https://longbridge.com/en/quote/09399.HK.md) - [CMCSV.US](https://longbridge.com/en/quote/CMCSV.US.md) - [SPIN.US](https://longbridge.com/en/quote/SPIN.US.md) ## Related News & Research - [Analyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts](https://longbridge.com/en/news/293780167.md) - [Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says](https://longbridge.com/en/news/293778081.md) - [CMCSA stock heads for fifth month of loss: Analysts trim price targets, say broadband recovery remains key to rebound](https://longbridge.com/en/news/293887664.md) - [BioCryst Pharmaceuticals (BCRX) Expected to Announce Quarterly Earnings on Wednesday](https://longbridge.com/en/news/294186102.md) - [Comcast Posts Modest Q2 Upside As NBCU, Sky Split May 'Drive Acquisition Interest'](https://longbridge.com/en/news/293777448.md)